1283090-73-2 Usage
Uses
Used in Pharmaceutical Industry:
7-fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine] is used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique molecular structure and pharmacological activities make it a promising candidate for the treatment of various bacterial and fungal infections.
Used in Research and Development:
7-fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine] is utilized in research and development for the exploration of its potential applications in medicinal chemistry. Its distinct molecular architecture and pharmacological properties provide a valuable foundation for the discovery of new therapeutic agents and the advancement of drug design strategies.
Used in Chemical Synthesis:
7-fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine] serves as a key intermediate in the synthesis of more complex organic compounds. Its unique structure and functional groups make it a valuable building block for the creation of novel molecules with potential applications in various fields, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1283090-73-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,3,0,9 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1283090-73:
(9*1)+(8*2)+(7*8)+(6*3)+(5*0)+(4*9)+(3*0)+(2*7)+(1*3)=152
152 % 10 = 2
So 1283090-73-2 is a valid CAS Registry Number.
1283090-73-2Relevant academic research and scientific papers
DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM
-
, (2011/04/24)
The present invention is directed to diarylmethylamide derivatives represented of structural formula I which are melanin-concentrating hormone receptor antagonists, and are useful as an agent for the prevention, treatment, or remedy of various circulatory diseases, neurological diseases, metabolic diseases, reproductive system diseases, respiratory diseases, digestive diseases, and the like. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the melanin-concentrating hormone is involved. I
